Two-Step Approach for the Prediction of Future Type 2 Diabetes Risk

September 2011
Diabetes Care;Sep2011, Vol. 34 Issue 9, p2108
Academic Journal
OBJECTIVE--To develop a model for the prediction of type 2 diabetes mellitus (T2DM) risk on the basis of a multivariate logistic model and 1-h plasma glucose concentration (1-h PG). RESEARCH DESIGN AND METHODS--The model was developed in a cohort of 1,562 nondiabetic subjects from the San Antonio Heart Study (SAHS) and validated in 2,395 nondiabetic subjects in the Botnia Study. A risk score on the basis of anthropometric parameters, plasma glucose and lipid profile, and blood pressure was computed for each subject. Subjects with a risk score above a certain cut point were considered to represent high-risk individuals, and their 1-h PG concentration during the oral glucose tolerance test was used to further refine their future T2DM risk. RESULTS--We used the San Antonio Diabetes Prediction Model (SADPM) to generate the initial risk score. A risk-score value of 0.065 was found to be an optimal cut point for initial screening and selection of high-risk individuals. A 1-h PG concentration > 140 mg/dL in high-risk individuals (whose risk score was >0.065) was the optimal cut point for identification of subjects at increased risk. The two cut points had 77.8, 77.4, and 44.8% (for the SAHS) and 75.8, 71.6, and 11.9% (for the Botnia Study) sensitivity, specificity, and positive predictive value, respectively, in the SAHS and Botnia Study. CONCLUSIONS--A two-step model, based on the combination of the SADPM and 1-h PG, is a useful tool for the identification of high-risk Mexican-American and Caucasian individuals.


Related Articles

  • Hemoglobin A1C for Diagnosis of Diabetes.  // RN;Jul2009, Vol. 72 Issue 7, p12 

    The article reports that Members of the American Diabetes Association, the International Diabetes Federation, and the European Association for the Study of Diabetes have determined that hemoglobin A1C (HbA1c) assays should be the method of diagnosis of type 2 diabetes. The test would replace...

  • How to Screen Obese Children at Risk for Type 2 Diabetes Mellitus? van der Aa, Marloes P.; Fazeli Farsani, Soulmaz; Kromwijk, Lisa A. J.; de Boer, Anthonius; Knibbe, Catherijne A. J.; van der Vorst, Marja M. J. // Clinical Pediatrics;Apr2014, Vol. 53 Issue 4, p337 

    Background. Recommended screening to identify children at risk for diabetes and its precursors impaired glucose tolerance (IGT) and insulin resistance (IR) is fasted plasma glucose (FPG). This study evaluates the added value of fasted plasma insulin (FPI). Methods. This study analyzed routinely...

  • Technology. Hammond, Peter // Diabetes Digest;2015, Vol. 14 Issue 3, p138 

    The article discusses the interpretation of glycemic patterns during patterns through the use of continuous glucose monitoring (CGM). It mentions that CGM is usually used to assist individuals with diabetes adjust their therapy, usually with insulin and diet. It cites several studies on the use...

  • Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults. Miao Mo; Weijian Zhong; Genming Zhao; Ye Ruan; Hua Zhang; Liang Shi; Dajiang Lu; Qundi Yang; Yanyun Li; Qingwu Jiang; Rui Li; Wang-Hong Xu // BMC Endocrine Disorders;2013, Vol. 13 Issue 1, p44 

    Background: Glycosylated hemoglobin A1c (HbA1c) has been applied to identify type 2 diabetes (T2DM) in the U.S. and European countries. It has not been used in China mainly due to lack of a standardized approach to measure HbA1c, short of knowledge about racial-specific standard and deficiency...

  • Glycemic biomarkers as tools for diagnosis and monitoring of diabetes. Gupta, Manjula K. // MLO: Medical Laboratory Observer;Mar2013, Vol. 45 Issue 3, p8 

    The article discusses the role of glycated protein biomarkers in the diagnosis and monitoring of diabetes. It mentions that glycated hemoglobin (HbA1C) is found accurate in assessing the mean blood glucose level and measuring the risk for the development of diabetes complications. It notes that...

  • Type 2 Diabetes Mellitus and Functional Hypoparathyroidism. Atmaca, Murat; Acar, İsmail; Gönültaş, Engin; Seven, İsmet; Üçler, Rıfkı; Ebinç, Senar; Alay, Murat; Candan, Zehra // Turkish Journal of Endocrinology & Metabolism;12/1/2014, Vol. 18 Issue 4, p116 

    Purpose: The present study aims to investigate the effect of blood sugar regulation and vitamin D levels on calcium metabolism and parathormone levels in patients with type 2 diabetes mellitus. Material and Method: We included 132 patients with type 2 diabetes mellitus who presented to our...

  • Your doctor says you have diabetes -- now what.  // South Asian Post;6/26/2014, p10 

    The article offers tips on what to do when someone is diagnosed with type two diabetes including how to manage blood sugar and the changes in lifestyle that can make a positive difference.

  • Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Saxena, Richa; Hivert, Marie-France; Langenberg, Claudia; Tanaka, Toshiko; Pankow, James S.; Vollenweider, Peter; Lyssenko, Valeriya; Bouatia-Naji, Nabila; Dupuis, Josée; Jackson, Anne U.; Linda Kao, W. H.; Man Li; Glazer, Nicole L.; Manning, Alisa K.; Jian'an Luan; Stringham, Heather M.; Prokopenko, Inga; Johnson, Toby; Grarup, Niels; Boesgaard, Trine W. // Nature Genetics;Feb2010, Vol. 42 Issue 2, p142 

    Glucose levels 2 h after an oral glucose challenge are a clinical measure of glucose tolerance used in the diagnosis of type 2 diabetes. We report a meta-analysis of nine genome-wide association studies (n = 15,234 nondiabetic individuals) and a follow-up of 29 independent loci (n =...

  • Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria. Leach, Mick; Evans, Philip H.; Pereira Gray, Denis J.; Wright, Christine; Langley, Peter; Gholap, Nitin; Davies, Melanie; Mostafa, Samiul; Khunti, Kamlesh // British Journal of General Practice;May2013, Vol. 63 Issue 610, p235 

    A letter to the editor is presented in response to the article about the diagnosis of type 2 diabetes mellitus (T2DM) using the new glycated haemoglobin (HbA1c) criteria, that was published in the February 2013 issue of the "British Journal of General Practice."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics